{"id":2241,"date":"2024-10-30T12:37:09","date_gmt":"2024-10-30T09:37:09","guid":{"rendered":"https:\/\/www.welovecycling.com\/ee\/?p=2241"},"modified":"2024-10-30T12:37:09","modified_gmt":"2024-10-30T09:37:09","slug":"kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist","status":"publish","type":"post","link":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/","title":{"rendered":"Kaalulangetusravimid \u2013 kas Sa peaksid kaaluma nende tarvitamist?"},"content":{"rendered":"<p><strong>Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad kaalust maha v\u00f5tta, peaks neid tarvitama? Kuidas nad \u00f5ieti aitavad kaalust maha v\u00f5tta, kuidas on lugu k\u00f5rvaltoimetega ja mis juhtub, kui tarvitamine l\u00f5petada? Anname vastused m\u00f5ningatele neist k\u00fcsimustest, et Sul oleks parem arusaam.<\/strong><\/p>\n<h3><strong>Kaalulangetusravimid aitavad Sul rohkem kaalu kaotada.<\/strong><\/h3>\n<p>Populaarsed GLP-1 agonistide klassi kaalulangetusravimid ei ole ainus viis kehakaalu v\u00e4hendamiseks. Paljud \u00fclekaalulised v\u00f5i rasvunud inimesed suudavad alla v\u00f5tta elustiili muutes. Kuid paljud ei suuda siiski sel viisil piisavalt kaalu kaotada. Kaalulangetustabletid koos elustiili muutusega aitavad m\u00e4rkimisv\u00e4\u00e4rselt rohkem alla v\u00f5tta.<\/p>\n<h3><strong>Aitavad Sul v\u00e4hem ravimeid tarvitada<\/strong><\/h3>\n<p>Kombinatsioon s\u00f6\u00f6gisedeli ja elustiili muutmisest ning kaalulangetusravimite v\u00f5tmisest t\u00e4hendab, et inimesed suudavad t\u00f5en\u00e4oliselt kaotada 15\u201320 protsenti kehakaalust. See v\u00e4ga oluline, sest niisuguse kaalukaotuse korral leevenevad \u00fcldiselt ka mitmed \u00fclekaaluga seotud terviseprobleemid:<\/p>\n<ul>\n<li>k\u00f5rge verer\u00f5hk<\/li>\n<li>diabeet<\/li>\n<li>rasvmaksa haigus<\/li>\n<li>uneapnoe<\/li>\n<\/ul>\n<p>Kui kaalulangetusravimid aitavad Sul vabaneda m\u00f5nega mainitud probleemidest, v\u00f5ib \u00fcldine tarbitav ravimikogus v\u00e4heneda ning leevenevad ka nendega seotud k\u00f5rvalm\u00f5jud.<\/p>\n<h3><strong>GLP-1 j\u00e4rele aimavad rohud parandavad tervist ka kaalukaotuseta<\/strong><\/h3>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2306963\">Uuringud<\/a> n\u00e4itavad, et GLP-1 v\u00f5ib v\u00e4hendada s\u00fcdamehaiguste ohtu ning diabeediga inimestel parandada neerude toimimist. Teoreetiliselt on k\u00f5igil organitel meie kehas olemas rakkudes GLP-1 retseptorid. Kui need rohud kinnituvad retseptoritele neerudes ja s\u00fcdames, tundub see kaitsvat neid organeid kahjustuste eest. Just sel p\u00f5hjusel nimetas Ameerika s\u00fcdameliit GLP-1 retseptori agonistid \u00fcheks 2023. aasta suuremaks edusammuks s\u00fcdame-veresoonkonna haiguste ravis.<\/p>\n<h3><strong>Need v\u00f5ivad olla abiks isegi s\u00f5ltuvusk\u00e4itumise korral<\/strong><\/h3>\n<p>Sellised kaalulangetusravimid nagu semaglutiid (Ozempic) on p\u00e4lvinud t\u00e4helepanu ka oma potentsiaaliga leevendada s\u00f5ltuvusi. Teadlased uurivad nende m\u00f5ju m\u00f5nuainete tarvitamisest tingitud h\u00e4irete korral. <a href=\"https:\/\/www.science.org\/content\/article\/hot-weight-loss-drugs-tested-addiction-treatments\">Esimesed katsed<\/a> olid paljulubavad, v\u00e4hendamaks iha alkoholi, nikotiini ja teiste s\u00f5ltuvust tekitavate ainete j\u00e4rele. Ent k\u00e4imasolevad uuringud on siiski vajalikud, et m\u00f5ista t\u00e4ielikult nende potentsiaali ja integreerimist s\u00f5ltuvuse ravi programmidesse.<\/p>\n<h3><strong>Arvestage k\u00f5rvalm\u00f5jusid<\/strong><\/h3>\n<p>Kaalulangetusravimite \u00fclalmainitud h\u00fcved on kahtlemata muljetavaldavad, kuid sarnaselt k\u00f5igile teistele ravimitele tuleb alati arvestada ka k\u00f5rvalm\u00f5judega.<\/p>\n<p>K\u00f5ige sagedasemad k\u00f5rvaltoimed on seotud seedimisega. GLP-1 agonistide p\u00f5hjustatud aeglasem k\u00f5hu t\u00fchjenemine v\u00f5ib p\u00f5hjustada iiveldust, k\u00f5hukinnisust ja muid seedetrakti probleeme. Nendega hakkamasaamine v\u00f5ib kujuneda p\u00e4ris keeruliseks, kui Sa samal ajal p\u00fc\u00fcad oma s\u00f6\u00f6misharjumusi parandada.<\/p>\n<p>Veel \u00fcks nende rohtudega saavutatud kaalukaotuse muret tegev m\u00f5ju on see, et umbes 30\u201340 protsenti kaalukaotusest tuleb \u201elahja massi\u201c arvelt. See t\u00e4hendab, et iga alla v\u00f5etud 10 kg kohta umbes 6\u20137 kg tuleb rasva arvelt, ent 3\u20134 kg lihastelt, luudelt ja muudel mitterasvkudedelt.<\/p>\n<p>Enamikuga neist k\u00f5rvaln\u00e4htudest on v\u00f5imalik siiski hakkama saada, eriti kui kasutada m\u00f5ningaid p\u00f5histrateegiaid, mida k\u00e4sitleme oma artikliseeria j\u00e4rgmises osas. Kuid on ka kahtlusi nende ravimite pikaajalise kasutamise suhtes. Ning kas saadud kasu j\u00e4\u00e4b alles, kui ravimite v\u00f5tmine l\u00f5petada?<\/p>\n<h3><strong>Mis juhtub, kui l\u00f5petada kaalulangetusravimite tarvitamine?<\/strong><\/h3>\n<p>Sinu kaal ei hakka muutuma kohe p\u00e4rast GLP-1 tarvitamise l\u00f5ppu, kuid n\u00e4lg ja ihad tulevad tagasi ning toidum\u00fcra ilmselt samuti. Kui Sa ei tegele oma men\u00fc\u00fc muutmise, kehaliste harjutuste ja muude elustiiliteguritega, on uue kaalu s\u00e4ilitamine v\u00e4ga keeruline. <a href=\"https:\/\/www.mdpi.com\/2077-0383\/12\/1\/145\">M\u00f5ned uuringud<\/a> n\u00e4itavadki, et inimestel, kes l\u00f5petasid Ozempicu tarvitamise, kogunes uuesti 66 protsenti kaotatud kaalust. See ongi p\u00f5hjus, mis alati tuleb \u00fchendada kaalulangetusravimid elustiili muutustega.<\/p>\n<h3><strong>Kas Sina peaksid v\u00f5tma kaalulangetusravimeid?<\/strong><\/h3>\n<p>Euroopas on sellised ravimid nagu Ozempic saadaval enamasti ainult retseptiga, nii et Sa ise tegelikult otsustada ei saa. Pead n\u00f5u pidama oma arstiga nagu igasuguste suuremate tervisealaste otsuste puhul. Kuid see artikkel aitab Sul arsti juurde minna paremini ette valmistunult. N\u00fc\u00fcd m\u00f5istad Sa potentsiaalseid h\u00fcvesid, k\u00f5rvalm\u00f5jusid ja tagasil\u00f6\u00f6ke. Arsti juurde minnes oskad esitada \u00f5igeid k\u00fcsimusi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad [&hellip;]<\/p>\n","protected":false},"author":174,"featured_media":2242,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[291,292,290,293],"global-categories":[22],"class_list":["post-2241","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tervis-trenn","tag-ozempic","tag-rybelsus","tag-ulekaalulisuse-ravim","tag-wegovy","global-categories-cycling"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.3 (Yoast SEO v25.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kaalulangetusravimid \u2013 kas Sa peaksid kaaluma nende tarvitamist? - \u0160koda We Love Cycling - Estonia<\/title>\n<meta name=\"description\" content=\"Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad kaalust maha v\u00f5tta, peaks neid tarvitama? Kuidas nad \u00f5ieti aitavad kaalust maha v\u00f5tta, kuidas on lugu k\u00f5rvaltoimetega ja mis juhtub, kui tarvitamine l\u00f5petada? Anname vastused m\u00f5ningatele neist k\u00fcsimustest, et Sul oleks parem arusaam.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kaalulangetusravimid \u2013 kas Sa peaksid kaaluma nende tarvitamist?\" \/>\n<meta property=\"og:description\" content=\"Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad kaalust maha v\u00f5tta, peaks neid tarvitama? Kuidas nad \u00f5ieti aitavad kaalust maha v\u00f5tta, kuidas on lugu k\u00f5rvaltoimetega ja mis juhtub, kui tarvitamine l\u00f5petada? Anname vastused m\u00f5ningatele neist k\u00fcsimustest, et Sul oleks parem arusaam.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/\" \/>\n<meta property=\"og:site_name\" content=\"\u0160koda We Love Cycling - Estonia\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-30T09:37:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"888\" \/>\n\t<meta property=\"og:image:height\" content=\"592\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"andre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ji\u0159\u00ed Kalo\u010d\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/\",\"url\":\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/\",\"name\":\"Kaalulangetusravimid \u2013 kas Sa peaksid kaaluma nende tarvitamist? - \u0160koda We Love Cycling - Estonia\",\"isPartOf\":{\"@id\":\"https:\/\/www.welovecycling.com\/ee\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp\",\"datePublished\":\"2024-10-30T09:37:09+00:00\",\"author\":{\"@id\":\"https:\/\/www.welovecycling.com\/ee\/#\/schema\/person\/8b7101c4bd1b1ae9d3732ebb1e6caf57\"},\"description\":\"Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad kaalust maha v\u00f5tta, peaks neid tarvitama? Kuidas nad \u00f5ieti aitavad kaalust maha v\u00f5tta, kuidas on lugu k\u00f5rvaltoimetega ja mis juhtub, kui tarvitamine l\u00f5petada? Anname vastused m\u00f5ningatele neist k\u00fcsimustest, et Sul oleks parem arusaam.\",\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/#primaryimage\",\"url\":\"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp\",\"contentUrl\":\"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp\",\"width\":888,\"height\":592},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.welovecycling.com\/ee\/#website\",\"url\":\"https:\/\/www.welovecycling.com\/ee\/\",\"name\":\"\u0160koda We Love Cycling - Estonia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.welovecycling.com\/ee\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.welovecycling.com\/ee\/#\/schema\/person\/8b7101c4bd1b1ae9d3732ebb1e6caf57\",\"name\":\"andre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\/\/www.welovecycling.com\/ee\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0656b3224fe17b018f43b8a562625dd43d30827f027b2f62bc5a05711fec9a61?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0656b3224fe17b018f43b8a562625dd43d30827f027b2f62bc5a05711fec9a61?s=96&d=mm&r=g\",\"caption\":\"andre\"},\"url\":\"https:\/\/www.welovecycling.com\/ee\/author\/andre\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kaalulangetusravimid \u2013 kas Sa peaksid kaaluma nende tarvitamist? - \u0160koda We Love Cycling - Estonia","description":"Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad kaalust maha v\u00f5tta, peaks neid tarvitama? Kuidas nad \u00f5ieti aitavad kaalust maha v\u00f5tta, kuidas on lugu k\u00f5rvaltoimetega ja mis juhtub, kui tarvitamine l\u00f5petada? Anname vastused m\u00f5ningatele neist k\u00fcsimustest, et Sul oleks parem arusaam.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/","og_locale":"et_EE","og_type":"article","og_title":"Kaalulangetusravimid \u2013 kas Sa peaksid kaaluma nende tarvitamist?","og_description":"Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad kaalust maha v\u00f5tta, peaks neid tarvitama? Kuidas nad \u00f5ieti aitavad kaalust maha v\u00f5tta, kuidas on lugu k\u00f5rvaltoimetega ja mis juhtub, kui tarvitamine l\u00f5petada? Anname vastused m\u00f5ningatele neist k\u00fcsimustest, et Sul oleks parem arusaam.","og_url":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/","og_site_name":"\u0160koda We Love Cycling - Estonia","article_published_time":"2024-10-30T09:37:09+00:00","og_image":[{"width":888,"height":592,"url":"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp","type":"image\/webp"}],"author":"andre","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ji\u0159\u00ed Kalo\u010d","Est. reading time":"4"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/","url":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/","name":"Kaalulangetusravimid \u2013 kas Sa peaksid kaaluma nende tarvitamist? - \u0160koda We Love Cycling - Estonia","isPartOf":{"@id":"https:\/\/www.welovecycling.com\/ee\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/#primaryimage"},"image":{"@id":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/#primaryimage"},"thumbnailUrl":"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp","datePublished":"2024-10-30T09:37:09+00:00","author":{"@id":"https:\/\/www.welovecycling.com\/ee\/#\/schema\/person\/8b7101c4bd1b1ae9d3732ebb1e6caf57"},"description":"Sellised ravimid nagu Ozempic, Wegovy v\u00f5i Rybelsus on osutunud kaalu langetamisel v\u00e4ga t\u00f5husaks. Kas see t\u00e4hendab, et k\u00f5ik, kes soovivad kaalust maha v\u00f5tta, peaks neid tarvitama? Kuidas nad \u00f5ieti aitavad kaalust maha v\u00f5tta, kuidas on lugu k\u00f5rvaltoimetega ja mis juhtub, kui tarvitamine l\u00f5petada? Anname vastused m\u00f5ningatele neist k\u00fcsimustest, et Sul oleks parem arusaam.","inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/www.welovecycling.com\/ee\/2024\/10\/30\/kaalulangetusravimid-kas-sa-peaksid-kaaluma-nende-tarvitamist\/#primaryimage","url":"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp","contentUrl":"https:\/\/d2p6e6u75xmxt8.cloudfront.net\/15\/2024\/10\/kaal1.webp","width":888,"height":592},{"@type":"WebSite","@id":"https:\/\/www.welovecycling.com\/ee\/#website","url":"https:\/\/www.welovecycling.com\/ee\/","name":"\u0160koda We Love Cycling - Estonia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.welovecycling.com\/ee\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Person","@id":"https:\/\/www.welovecycling.com\/ee\/#\/schema\/person\/8b7101c4bd1b1ae9d3732ebb1e6caf57","name":"andre","image":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/www.welovecycling.com\/ee\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0656b3224fe17b018f43b8a562625dd43d30827f027b2f62bc5a05711fec9a61?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0656b3224fe17b018f43b8a562625dd43d30827f027b2f62bc5a05711fec9a61?s=96&d=mm&r=g","caption":"andre"},"url":"https:\/\/www.welovecycling.com\/ee\/author\/andre\/"}]}},"_links":{"self":[{"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/posts\/2241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/users\/174"}],"replies":[{"embeddable":true,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/comments?post=2241"}],"version-history":[{"count":1,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/posts\/2241\/revisions"}],"predecessor-version":[{"id":2243,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/posts\/2241\/revisions\/2243"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/media\/2242"}],"wp:attachment":[{"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/media?parent=2241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/categories?post=2241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/tags?post=2241"},{"taxonomy":"global-categories","embeddable":true,"href":"https:\/\/www.welovecycling.com\/ee\/wp-json\/wp\/v2\/global-categories?post=2241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}